Colgate-Palmolive Company (NYSE:CL) reported second-quarter FY24 sales growth of 4.9% year-on-year to $5.058 billion, beating the analyst consensus estimate of $5.010 billion. Organic sales increased by 9%. Total Oral, Personal, and Home Care net sales increased by 4.7% to $3.94 billion. Non-GAAP EPS of $0.91 beat the analyst consensus of $0.87. Gross profit was $3.06 billion, while the margin expanded 280 basis points to 60.6%. Selling, general and administrative expenses rose 9.7% to $1.94 billion. Operating margin expanded 140 basis points to 21.6%, ...